
Tuesday 1st July, 12-1pm
3rd Floor Conference Room, Building 75, Clayton Campus
It is now well established that a cancer’s mutational burden drives tumour formation, influences disease progression and can dictate its sensitivity to chemotherapy. The Grimmond Laboratory has pioneered large-scale cancer genome sequencing (>pancreatic, ovarian and oesophageal) primarily as part of Australia’s International Cancer Genome Consortium effort. See attached flyer for details.
No comments:
Post a Comment